Intramuscular Aripiprazole in Acutely Agitated Patients Diagnosed With Dementia

Completed · Phase 3 · Has a placebo group

Conditions studied: Dementia, Alzheimer's Disease

In brief

The purpose of this trial is to test the safety \& tolerability of intramuscular aripiprazole in acutely agitated patients diagnosed with Dementia.

Key facts

Study ID

NCT00095719

Run by

Otsuka Pharmaceutical Development & Commercialization, Inc.

People needed

125

Starts

2003-12-01

Expected to finish

2005-03-01

Last updated by the study team

2013-11-11

Who can join

Age: 55 and older, up to 95. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Acute agitation in Patients with a DSM-IV diagnosis of Alzheimer's, vascular or mixed Dementia.

You may not qualify if…

• Current DSM-IV Axis 1 diagnosis other than Alzheimer's, vascular or mixed Dementia.

Where it is running

• Local Institution — Santa Ana, California, United States
• Local Institution — Hamden, Connecticut, United States
• Local Institution — Hialeah, Florida, United States
• Local Institution — Miami, Florida, United States
• Local Institution — North Miami, Florida, United States
• Local Institution — Indianapolis, Indiana, United States
• Local Institution — New York, New York, United States
• Local Institution — Staten Island, New York, United States
• Local Institution — Dayton, Ohio, United States
• Local Institution — Oklahoma City, Oklahoma, United States
• Local Institution — Tulsa, Oklahoma, United States
• Local Institution — Hershey, Pennsylvania, United States
• Local Institution — Austin, Texas, United States
• Local Institution — Midvale, Utah, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.